TY - JOUR
T1 - A multi-locus genetic risk score for abdominal aortic aneurysm
AU - Ye, Zi
AU - Austin, Erin
AU - Schaid, Daniel J.
AU - Kullo, Iftikhar J.
N1 - Funding Information:
All authors have approved submission of the manuscript. We thank the staff of the Medical Genome Facility Genotyping Core (GTC) at the Mayo Clinic for carrying out the genotyping for this study. The GTC is supported in part by the NCI Cancer Center Support Grant P30 CA 15083 . Dr. Kullo was supported by grant U01 HG-06379 from the National Human Genome Research Institute . The publication was made possible by Center for translational Science Activities Grant UL1 TR000135 from the National Center for Advancing Translational Sciences , a component of the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. Authors have nothing to disclose and have no relationships to industry.
Funding Information:
We express our gratitude to all individuals who participate in the Netherlands Epidemiology in Obesity study. We are grateful to all participating general practitioners for inviting eligible participants. We furthermore thank all research nurses for collecting the data and I. de Jonge, MSc for all data management of the NEO study. The NEO study is supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Center, and by the Leiden University, Research Profile Area ‘Vascular and Regenerative Medicine’. This work was further supported by ‘the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences’ for the ENERGISE project ‘Targeting energy metabolism to combat cardiovascular disease’ (CVON2014-2). P.C.N. Rensen is an Established Investigator of the Dutch Heart Foundation (2009T038). L.L. Blauw is supported by a grant from the Board of Directors of the Leiden University Medical Center. The NEO study group consists of: Frits R. Rosendaal, Renee de Mutsert, Ton J. Rabelink, J.Wouter Jukema, Albert de Roos, Saskia le Cessie, Pieter S. Hiemstra, Margreet Kloppenburg, Tom W.J. Huizinga, Hanno Pijl, Eelco J.P. de Koning, Pieter H. Reitsma, Ko Willems van Dijk, Aiko P.J. de Vries, Hildo J. Lamb, Ingrid M. Jazet, Olaf M. Dekkers, Nienke R. Biermasz, Jeanet W. Blom, Patrick C.N. Rensen, Christa M. Cobbaert (Leiden University and Medical Center, Leiden, the Netherlands), Martin den Heijer, Jacqueline M. Dekker and Brenda W. Penninx (VU Medical Center, Amsterdam, The Netherlands).
Publisher Copyright:
© 2015.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Background: We investigated whether a multi-locus genetic risk scores (GRS) was associated with presence and progression of abdominal aortic aneurysm (AAA) in a case - control study. Methods and Results: The study comprised of 1124 patients with AAA (74 ± 8 years, 83% men, 52% of them with a maximal AAA size ≤ 5 cm) and 6524 non-cases (67 ± 11 years, 58% men) from the Mayo Vascular Disease Biorepository. AAA was defined as infrarenal abdominal aorta diameter ≥3.0 cm or history of AAA repair. Non-cases were participants without known AAA. A GRS was calculated using 4 SNPs associated with AAA at genome-wide significance (P ≤ 10-8). The GRS was associated with the presence of AAA after adjustment for age, sex, cardiovascular risk factors, atherosclerotic cardiovascular diseases and family history of aortic aneurysm: odds ratio (OR, 95% confidence interval, CI) 1.06 (1.04-1.09, p < 0.001). Adding GRS to conventional risk factors improved the association of presence of AAA (net reclassification index 14%, p < 0.001). In a subset of patients with AAA who had ≥2 imaging studies (n = 651, mean (SE) growth rate 2.47 (0.11) mm/year during a mean time interval of 5.41years), GRS, baseline size, diabetes and family history were each associated with aneurysm growth rate in univariate association (all p < 0.05). The estimated mean aneurysm growth rate was 0.50 mm/year higher in those with GRS > median (5.78) than those with GRS ≤ median (p = 0.01), after adjustment for baseline size (p < 0.001), diabetes (p = 0.046) and family history of aortic aneurysm (p = 0.02). Conclusions: A multi-locus GRS was associated with presence of AAA and greater aneurysm expansion.
AB - Background: We investigated whether a multi-locus genetic risk scores (GRS) was associated with presence and progression of abdominal aortic aneurysm (AAA) in a case - control study. Methods and Results: The study comprised of 1124 patients with AAA (74 ± 8 years, 83% men, 52% of them with a maximal AAA size ≤ 5 cm) and 6524 non-cases (67 ± 11 years, 58% men) from the Mayo Vascular Disease Biorepository. AAA was defined as infrarenal abdominal aorta diameter ≥3.0 cm or history of AAA repair. Non-cases were participants without known AAA. A GRS was calculated using 4 SNPs associated with AAA at genome-wide significance (P ≤ 10-8). The GRS was associated with the presence of AAA after adjustment for age, sex, cardiovascular risk factors, atherosclerotic cardiovascular diseases and family history of aortic aneurysm: odds ratio (OR, 95% confidence interval, CI) 1.06 (1.04-1.09, p < 0.001). Adding GRS to conventional risk factors improved the association of presence of AAA (net reclassification index 14%, p < 0.001). In a subset of patients with AAA who had ≥2 imaging studies (n = 651, mean (SE) growth rate 2.47 (0.11) mm/year during a mean time interval of 5.41years), GRS, baseline size, diabetes and family history were each associated with aneurysm growth rate in univariate association (all p < 0.05). The estimated mean aneurysm growth rate was 0.50 mm/year higher in those with GRS > median (5.78) than those with GRS ≤ median (p = 0.01), after adjustment for baseline size (p < 0.001), diabetes (p = 0.046) and family history of aortic aneurysm (p = 0.02). Conclusions: A multi-locus GRS was associated with presence of AAA and greater aneurysm expansion.
KW - Abdominal aortic aneurysm
KW - Genetic risk score
KW - Genetics
UR - http://www.scopus.com/inward/record.url?scp=84955308330&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955308330&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2015.12.031
DO - 10.1016/j.atherosclerosis.2015.12.031
M3 - Article
C2 - 26820802
AN - SCOPUS:84955308330
SN - 0021-9150
VL - 246
SP - 274
EP - 279
JO - Atherosclerosis
JF - Atherosclerosis
ER -